<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>AN2 Therapeutics, Inc. (ANTX) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/antx/filings</link>
    <description>Latest company filings for AN2 Therapeutics, Inc. (ANTX) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Sat, 11 Jul 2026 21:53:13 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/antx/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[ANTX: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000207367926000066/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0002073679-26-000066</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526216755/antx-20260331.htm</link>
      <guid isPermaLink="false">0001193125-26-216755</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Quarterly report (10-Q) on 2026-05-11.]]></description>
      <pubDate>Mon, 11 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526216752/antx-20260511.htm</link>
      <guid isPermaLink="false">0001193125-26-216752</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Major company event (8-K) on 2026-05-11.]]></description>
      <pubDate>Mon, 11 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Annual report to shareholders (ARS)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526170328/antx-ars-2026.pdf</link>
      <guid isPermaLink="false">0001193125-26-170328</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Annual report to shareholders (ARS) on 2026-04-22.]]></description>
      <pubDate>Wed, 22 Apr 2026 12:00:00 GMT</pubDate>
      <category>ARS</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526170321/antx-defa14a-2025.htm</link>
      <guid isPermaLink="false">0001193125-26-170321</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Proxy materials (DEFA14A) on 2026-04-22.]]></description>
      <pubDate>Wed, 22 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526170314/antx-20260422.htm</link>
      <guid isPermaLink="false">0001193125-26-170314</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Proxy statement (DEF 14A) on 2026-04-22.]]></description>
      <pubDate>Wed, 22 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[ANTX: EFFECT]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/999999999526001256/xslEFFECTX01/primary_doc.xml</link>
      <guid isPermaLink="false">9999999995-26-001256</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a EFFECT (EFFECT) on 2026-04-20.]]></description>
      <pubDate>Mon, 20 Apr 2026 12:00:00 GMT</pubDate>
      <category>EFFECT</category>
    </item>
    <item>
      <title><![CDATA[ANTX: 424B3]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526164101/d293011d424b3.htm</link>
      <guid isPermaLink="false">0001193125-26-164101</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a 424B3 (424B3) on 2026-04-20.]]></description>
      <pubDate>Mon, 20 Apr 2026 12:00:00 GMT</pubDate>
      <category>424B3</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526164095/d802804d424b5.htm</link>
      <guid isPermaLink="false">0001193125-26-164095</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Prospectus supplement (424B5) on 2026-04-20.]]></description>
      <pubDate>Mon, 20 Apr 2026 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Company correspondence (CORRESP)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526158794/filename1.htm</link>
      <guid isPermaLink="false">0001193125-26-158794</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Company correspondence (CORRESP) on 2026-04-16.]]></description>
      <pubDate>Thu, 16 Apr 2026 12:00:00 GMT</pubDate>
      <category>CORRESP</category>
    </item>
    <item>
      <title><![CDATA[ANTX: SEC correspondence (UPLOAD)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000000000026003830/filename1.pdf</link>
      <guid isPermaLink="false">0000000000-26-003830</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a SEC correspondence (UPLOAD) on 2026-04-15.]]></description>
      <pubDate>Wed, 15 Apr 2026 12:00:00 GMT</pubDate>
      <category>UPLOAD</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526151632/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-151632</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-04-10.]]></description>
      <pubDate>Fri, 10 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526151628/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-151628</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-04-10.]]></description>
      <pubDate>Fri, 10 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526151626/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-151626</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-04-10.]]></description>
      <pubDate>Fri, 10 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Securities registration (S-3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526149869/d44885ds3.htm</link>
      <guid isPermaLink="false">0001193125-26-149869</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Securities registration (S-3) on 2026-04-09.]]></description>
      <pubDate>Thu, 09 Apr 2026 12:00:00 GMT</pubDate>
      <category>S-3</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526149822/d127053d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-149822</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Major company event (8-K) on 2026-04-09.]]></description>
      <pubDate>Thu, 09 Apr 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ANTX: D]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000188043826000001/xslFormDX01/primary_doc.xml</link>
      <guid isPermaLink="false">0001880438-26-000001</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a D (D) on 2026-03-25.]]></description>
      <pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
      <category>D</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526120236/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-120236</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526120235/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-120235</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526120230/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-120230</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526120226/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-120226</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526120223/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-120223</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526120221/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-120221</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526120216/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-120216</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526120214/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-120214</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526120210/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-120210</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526120207/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-120207</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526120200/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-120200</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526120192/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-120192</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526117765/d107794d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-117765</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Major company event (8-K) on 2026-03-20.]]></description>
      <pubDate>Fri, 20 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526110791/antx-20260317.htm</link>
      <guid isPermaLink="false">0001193125-26-110791</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Employee stock plan (S-8) on 2026-03-17.]]></description>
      <pubDate>Tue, 17 Mar 2026 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526110693/antx-20251231.htm</link>
      <guid isPermaLink="false">0001193125-26-110693</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Annual report (10-K) on 2026-03-17.]]></description>
      <pubDate>Tue, 17 Mar 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526110681/antx-20260317.htm</link>
      <guid isPermaLink="false">0001193125-26-110681</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Major company event (8-K) on 2026-03-17.]]></description>
      <pubDate>Tue, 17 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ANTX: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000183194226000014/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001831942-26-000014</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-03-16.]]></description>
      <pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[ANTX: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000121390026027660/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001213900-26-027660</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-03-13.]]></description>
      <pubDate>Fri, 13 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[ANTX: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000110465926027730/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001104659-26-027730</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-03-13.]]></description>
      <pubDate>Fri, 13 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526099169/d14366d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-099169</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Major company event (8-K) on 2026-03-10.]]></description>
      <pubDate>Tue, 10 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526094490/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-094490</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-03-05.]]></description>
      <pubDate>Thu, 05 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526064176/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-064176</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-02-23.]]></description>
      <pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526064174/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-064174</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-02-23.]]></description>
      <pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526064166/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-064166</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-02-23.]]></description>
      <pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526064151/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-064151</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-02-23.]]></description>
      <pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526064141/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-064141</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-02-23.]]></description>
      <pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526064105/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-064105</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-02-23.]]></description>
      <pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526064103/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-064103</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-02-23.]]></description>
      <pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526064089/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-064089</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-02-23.]]></description>
      <pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526064069/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-064069</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-02-23.]]></description>
      <pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526064061/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-064061</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-02-23.]]></description>
      <pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526064059/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-064059</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-02-23.]]></description>
      <pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ANTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1880438/000119312526064028/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-064028</guid>
      <description><![CDATA[AN2 Therapeutics, Inc. filed a Insider trade (4) on 2026-02-23.]]></description>
      <pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
  </channel>
</rss>